CND Life Sciences is continuing to add to its Syn-One Clinician Network, a directory of…
Editorial TeamOctober 30, 2024
Find out what’s on the minds of the team at CND Life Sciences.
A core value of CND Life Sciences is putting patients first. We understand that when…
Editorial TeamSeptember 26, 2024
As an interface to the outside world and the largest organ in the body, the…
Padma R. Mahant MDAugust 12, 2024
CND Life Sciences’ Director of Medical Affairs Discusses Syn-One Test® With Synapticure Neurologists
Dr. Padma Mahant, MD, Director of Medical Affairs at CND Life Sciences, recently participated in…
Editorial TeamJuly 15, 2024
Dr. Christopher Gibbons Discusses Synuclein-One Study Results and Implications on Neurology® Podcast
Dr. Jeff Ratliff of the Neurology® Podcast recently interviewed Dr. Christopher Gibbons, Senior Scientific Advisor…
Editorial TeamJuly 8, 2024
After a US Senate vote on May 23, 2024, the “Dr. Emmanuel Bilirakis and Honorable…
Editorial TeamJune 11, 2024
If you’d like to learn more about the Syn-One Test, the scientific research that is…
Editorial TeamJune 6, 2024
Quality skin punch biopsies are foundational to utilizing CND Life Sciences’ diagnostic testing platform to…
Editorial TeamMay 30, 2024
On the heels of the highly anticipated publication of the NIH-supported Synuclein-One Study in JAMA,…
Editorial TeamApril 22, 2024
“Patients first” is a core value at CND Life Sciences. We understand that behind every…
Sarah WinterApril 9, 2024
If you’re considering implementing the Syn-One Test® in your practice, you probably have several questions…
Editorial TeamMarch 27, 2024
“Genetics loads the gun and environment pulls the trigger” is often invoked when discussing the…
Padma R. Mahant MDMarch 13, 2024
NeurologyLive’s MEDcast recently released an episode titled “Paradigm Shift in Parkinson’s Disease Diagnosis” that included…
Editorial TeamFebruary 13, 2024
As 2023 drew to a close, the Parkinson’s community worked together to bring important legislation…
Padma R. Mahant MDFebruary 7, 2024
Neurodegenerative diseases like Parkinson’s and dementias continue to represent some of the most significant threats…
Todd Levine MDJanuary 11, 2024
In our prior Insights articles exploring systems involved in the pathogenesis of Parkinson’s disease, we…
Padma R. Mahant MDJanuary 4, 2024
In our last Insights article, we discussed the relationship between a variety of gastrointestinal conditions…
Padma R. Mahant MDNovember 8, 2023
Padma Mahant, MD, joined CND Life Sciences in May 2023 as Director of Medical Affairs,…
Editorial TeamOctober 31, 2023
The Davis Phinney Foundation, whose mission is to help people living with Parkinson’s disease to…
Editorial TeamOctober 24, 2023
Parkinson’s disease pathology starts years, even decades, before symptoms develop, and several studies support the…
Padma R. Mahant MDOctober 3, 2023
The Syn-One Test is the first commercially available test of its kind, developed to aid…
Editorial TeamSeptember 15, 2023
The mission of CND Life Sciences—to advance the care of patients who face the potential…
Editorial TeamSeptember 5, 2023
The mission of the medical diagnostic laboratory at CND Life Sciences is to provide the…
Editorial TeamAugust 9, 2023
A study published last month in npj Parkinson’s Disease highlights disparities in health care utilization…
Editorial TeamAugust 2, 2023
CND Life Sciences’ Chief Medical Officer and Co-Founder Dr. Todd Levine was awarded a Best…
Editorial TeamJune 28, 2023
Across an array of neurologic diseases, there is often a lack of objective diagnostic testing.…
Todd Levine MDMay 31, 2023
Dr. Christopher Gibbons was interviewed by Dr. Jason Crowell last week on the Neurology® podcast…
Editorial TeamApril 20, 2023
A recent paper published in Neurology and co-authored by two of CND Life Sciences’ co-founders,…
Todd Levine MDMarch 20, 2023
As CND Life Sciences continues to experience growth, launch new diagnostic tests, and expand its…
Editorial TeamMarch 13, 2023
Clinicians often encounter patients who do not fit neatly into one diagnostic bucket. These cases…
Todd Levine MDJanuary 6, 2023
The mission of the clinical laboratory at CND Life Sciences—to provide timely and accurate test…
Editorial TeamOctober 21, 2022
CND Life Sciences is pleased to announce the launch of the Syn-One Clinician Network, a…
Todd Levine MDOctober 3, 2022
Over 2 million people in the US have a synucleinopathy, and 100,000 are diagnosed every…
Todd Levine MDSeptember 20, 2022
Helping clinicians care for patients and putting patients first are core values at CND Life…
Editorial TeamJuly 20, 2022
CND Life Sciences’ senior scientific advisors Dr. Christopher Gibbons and Dr. Roy Freeman and two…
Editorial TeamJune 27, 2022
Kendall Swanson started at CND Life Sciences as an intern in the summer before her…
Editorial TeamJune 21, 2022
A large, population-based study of UK residents demonstrated that a variety of symptoms may be…
Todd Levine MDJune 14, 2022
A recent case series report in Movement Disorders examines the potential limitations of dopamine transporter…
Todd Levine MDJune 1, 2022
Drs. Pravin Khemani and Michael Elliot from Swedish Neuroscience Institute in Seattle, Washington, published a…
Editorial TeamMay 10, 2022
The methodology behind the Synuclein-One Study, the largest study to date of cutaneous phosphorylated alpha-synuclein…
Editorial TeamApril 21, 2022
More than 300 million people, or 5% of the worldwide population, are living with a…
Editorial TeamFebruary 25, 2022
Most neurodegenerative disorders are linked to some form of protein misfolding, which results in accumulation…
Editorial TeamJanuary 27, 2022
Arriving at a definitive diagnosis of any given neurodegenerative condition is not always easy. Recent…
Editorial TeamJanuary 11, 2022
A core value at CND Life Sciences is being clinician-minded. We are founded by practicing…
Editorial TeamDecember 14, 2021
In CND Life Sciences’ newest case study, Dr. Todd Levine describes the case of a…
Editorial TeamDecember 7, 2021
Dr. Todd Levine, CND Life Sciences’ Co-Founder and CMO, will speak at the product presentation…
Todd Levine MDNovember 2, 2021
Dr. Todd Levine, CND Life Sciences’ Co-Founder and CMO, will speak at the product presentation…
Editorial TeamOctober 5, 2021
Having a core mission is foundational for any endeavor, and ours at CND Life Sciences…
Editorial TeamAugust 23, 2021
CND Life Sciences introduced clinicians to the Syn-One Test™ at the exhibit hall of Vanderbilt…
Editorial TeamAugust 17, 2021
Al-Qassabi and colleagues recently published a study in Movement Disorders that examined whether 3-mm skin…
Todd Levine MDJuly 8, 2021
CND Life Sciences continues to increase awareness and adoption of the skin-based Syn-One Test™ for…
Editorial TeamJune 22, 2021
At the 2021 American Academy of Neurology meeting last month, Dr Alexandru Barboi and colleagues…
Todd Levine MDMay 27, 2021
In the next installment of our Patient Matters video series, Daryn Kagan talks with Alvin,…
Editorial TeamApril 20, 2021
In a new effort to increase awareness and adoption of the skin-based Syn-One Test™ for…
Editorial TeamApril 14, 2021
Do you know how many people in the US are diagnosed with Parkinson’s disease each…
Editorial TeamApril 8, 2021
Rare Disease Day is February 28, 2021. EURORDIS, the organizer of Rare Disease Day, works…
Editorial TeamFebruary 24, 2021
A core value of CND Life Sciences is putting patients first. We understand that there’s…
Editorial TeamJanuary 29, 2021
In the November 2020 issue of Movement Disorders, Dommershuijsen and his fellow researchers in the…
Todd Levine MDJanuary 19, 2021
It is 4:30 AM and you are sound asleep. Suddenly your significant other screams and…
Christopher Gibbons MD, MMScDecember 2, 2020
The identification of a reliable biomarker in neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s...
Todd Levine MDNovember 10, 2020
Orthostatic hypotension (OH), a drop in blood pressure upon standing that might cause you to…
Editorial TeamOctober 15, 2020
Perhaps there has been no other time in the last century when the topic of…
Richard J. MorelloMay 1, 2020
Neurodegenerative diseases like Parkinson’s and dementias continue to represent some of the most significant threats…
Todd Levine MDApril 30, 2020
For Clinicians: Request a Skin Biopsy Test Kit
Our suite of neurodiagnostic tests provides clinicians with objective pathological insights on diseases that are often difficult to diagnose. Using our Skin Biopsy Test Kit, collect three small skin biopsies from your patient, send them to our CLIA-certified and CAP-accredited lab, and CND will provide important pathological insights to support a diagnosis.
Order a Kit
